Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
ARGOS THERAPEUTICS INCListing unverified | Other | $79.2M | SEC | ||
ARGOS THERAPEUTICS INCListing unverified | Buy | $129.5K | conv 25Cluster | SEC | |
ARGOS THERAPEUTICS INCListing unverified | Buy | $69.5K | conv 24Cluster | SEC | |
ARGOS THERAPEUTICS INCListing unverified | Buy | $81.2K | conv 25Cluster | SEC | |
ARGOS THERAPEUTICS INCListing unverified | Buy | $252.4K | conv 33Cluster | SEC | |
ARGOS THERAPEUTICS INCListing unverified | Buy | $93.5K | conv 33Cluster | SEC | |
ARGOS THERAPEUTICS INCListing unverified | Buy | $226.4K | conv 33Cluster | SEC | |
ARGOS THERAPEUTICS INCListing unverified | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC | |
ARGOS THERAPEUTICS INCListing unverified | Buy | n/a (No price was disclosed in the filing) | conv 51ClusterFirst in 12mo | SEC |